{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:34:01Z","timestamp":1794864841469,"version":"4.9.1"},"reference-count":224,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004362","name":"Swiss Heart Foundation","doi-asserted-by":"publisher","award":["FF20094"],"award-info":[{"award-number":["FF20094"]}],"id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foundation of Cardiovascular Research\u2014Zurich Heart House"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL136431"],"award-info":[{"award-number":["R01HL136431"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL141917"],"award-info":[{"award-number":["R01HL141917"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL147095"],"award-info":[{"award-number":["R01HL147095"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Calcific aortic valve disease (CAVD) is a highly prevalent condition that comprises a disease continuum, ranging from microscopic changes to profound fibro-calcific leaflet remodelling, culminating in aortic stenosis, heart failure, and ultimately premature death. Traditional risk factors, such as hypercholesterolaemia and (systolic) hypertension, are shared among atherosclerotic cardiovascular disease and CAVD, yet the molecular and cellular mechanisms differ markedly. Statin-induced low-density lipoprotein cholesterol lowering, a remedy highly effective for secondary prevention of atherosclerotic cardiovascular disease, consistently failed to impact CAVD progression or to improve patient outcomes. However, recently completed phase II trials provide hope that pharmaceutical tactics directed at other targets implicated in CAVD pathogenesis offer an avenue to alter the course of the disease non-invasively. Herein, we delineate key players of CAVD pathobiology, outline mechanisms that entail compromised endothelial barrier function, and promote lipid homing, immune-cell infiltration, and deranged phospho-calcium metabolism that collectively perpetuate a pro-inflammatory\/pro-osteogenic milieu in which valvular interstitial cells increasingly adopt myofibro-\/osteoblast-like properties, thereby fostering fibro-calcific leaflet remodelling and eventually resulting in left ventricular outflow obstruction. We provide a glimpse into the most promising targets on the horizon, including lipoprotein(a), mineral-binding matrix Gla protein, soluble guanylate cyclase, dipeptidyl peptidase-4 as well as candidates involved in regulating phospho-calcium metabolism and valvular angiotensin II synthesis and ultimately discuss their potential for a future therapy of this insidious disease.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehab757","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T18:50:59Z","timestamp":1634755859000},"page":"683-697","source":"Crossref","is-referenced-by-count":256,"title":["Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8245-7287","authenticated-orcid":false,"given":"Simon","family":"Kraler","sequence":"first","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse 12, 8952 Schlieren, Switzerland"},{"name":"University Heart Center, Department of Cardiology, University Hospital , R\u00e4mistrasse 100, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-9786","authenticated-orcid":false,"given":"Mark C","family":"Blaser","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , 3 Blackfan Street, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Aikawa","sequence":"additional","affiliation":[{"name":"Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , 3 Blackfan Street, Boston, MA 02115, USA"},{"name":"Center for Excellence in Vascular Biology, Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , 77 Ave Louis Pasteur, NRB7, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0523-0695","authenticated-orcid":false,"given":"Giovanni G","family":"Camici","sequence":"additional","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse 12, 8952 Schlieren, Switzerland"},{"name":"University Heart Center, Department of Cardiology, University Hospital , R\u00e4mistrasse 100, 8091 Zurich, Switzerland"},{"name":"Department of Research and Education, University Hospital Zurich , R\u00e4mistrasse 100, 8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5259-538X","authenticated-orcid":false,"given":"Thomas F","family":"L\u00fcscher","sequence":"additional","affiliation":[{"name":"Center for Molecular Cardiology, University of Zurich , Wagistrasse 12, 8952 Schlieren, Switzerland"},{"name":"Heart Division, Royal Brompton & Harefield Hospitals , Sydney Street, London SW3 6NP, UK"},{"name":"National Heart and Lung Institute, Imperial College , Guy Scadding Building, Dovehouse Street, London SW3 6LY, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,25]]},"reference":[{"key":"2022102517141517900_ehab757-B1","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jacc.2007.07.064","article-title":"Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease. The Cardiovascular Health Study","volume":"50","author":"Novaro","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B2","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/eurheartj\/ehs171","article-title":"Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeutics","volume":"33","author":"Sverdlov","year":"2012","journal-title":"Eur Heart J"},{"key":"2022102517141517900_ehab757-B3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0002-9149(02)03011-4","article-title":"Progression of aortic valve sclerosis to aortic stenosis","volume":"91","author":"Faggiano","year":"2003","journal-title":"Am J Cardiol"},{"key":"2022102517141517900_ehab757-B4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199907153410302","article-title":"Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly","volume":"341","author":"Otto","year":"1999","journal-title":"N Engl J Med"},{"key":"2022102517141517900_ehab757-B5","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","article-title":"The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis","volume":"63","author":"Coffey","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/ehjci\/jeaa263","article-title":"Prevalence and clinical implications of valvular calcification on coronary computed tomography angiography","volume":"22","author":"Williams","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022102517141517900_ehab757-B7","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.2019.6292","article-title":"Mortality due to aortic stenosis in the United States, 2008-2017","volume":"321","author":"Bevan","year":"2019","journal-title":"JAMA"},{"key":"2022102517141517900_ehab757-B8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"2022102517141517900_ehab757-B9","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology\/","volume":"143","author":"Otto","year":"2021","journal-title":"American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation"},{"key":"2022102517141517900_ehab757-B10","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/heartjnl-2014-307020","article-title":"The modern epidemiology of heart valve disease","volume":"102","author":"Coffey","year":"2016","journal-title":"Heart"},{"key":"2022102517141517900_ehab757-B12","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.119.043391","article-title":"Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990\u20132017","volume":"141","author":"Yadgir","year":"2020","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/heartjnl-2012-302265","article-title":"The evolving epidemiology of valvular aortic stenosis. The Troms\u00f8 Study","volume":"99","author":"Eveborn","year":"2013","journal-title":"Heart"},{"key":"2022102517141517900_ehab757-B14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"key":"2022102517141517900_ehab757-B15","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/heartjnl-2021-319025","article-title":"Cumulative burden of clinically significant aortic stenosis in community-dwelling older adults","volume":"107","author":"Owens","year":"2021","journal-title":"Heart"},{"key":"2022102517141517900_ehab757-B16","doi-asserted-by":"crossref","first-page":"e001345","DOI":"10.1136\/openhrt-2020-001345","article-title":"Differences in the presentation and management of patients with severe aortic stenosis in different European centres","volume":"7","author":"Lutz","year":"2020","journal-title":"Open Heart"},{"key":"2022102517141517900_ehab757-B17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/CIRCRESAHA.116.309306","article-title":"Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis","volume":"120","author":"Simard","year":"2017","journal-title":"Circ Res"},{"key":"2022102517141517900_ehab757-B18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0735-1097(96)00440-8","article-title":"Age dependency of left ventricular diastolic function in pressure overload hypertrophy","volume":"29","author":"Villari","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCHEARTFAILURE.110.960039","article-title":"The adverse impact of diabetes mellitus on left ventricular remodeling and function in patients with severe aortic stenosis","volume":"4","author":"Lindman","year":"2011","journal-title":"Circ Heart Fail"},{"key":"2022102517141517900_ehab757-B20","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.jacc.2009.11.083","article-title":"Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis. A substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin)","volume":"55","author":"Pag\u00e9","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B21","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/01.CIR.86.4.1336","article-title":"Sex-associated differences in left ventricular function in aortic stenosis of the elderly","volume":"86","author":"Buttrick","year":"1992","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B22","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1161\/01.CIR.0000074211.28917.31","article-title":"Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis","volume":"107","author":"Rajappan","year":"2003","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/hc0402.102931","article-title":"Mechanisms of coronary microcirculatory dysfunction in patients with aortic stenosis and angiographically normal coronary arteries","volume":"105","author":"Rajappan","year":"2002","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B24","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.CIR.95.4.892","article-title":"Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts","volume":"95","author":"Julius","year":"1997","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","article-title":"Progression from compensated hypertrophy to failure in the pressure-overloaded human: heart structural deterioration and compensatory mechanisms","volume":"107","author":"Hein","year":"2003","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurheartj\/ehx353","article-title":"Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients","volume":"39","author":"Treibel","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102517141517900_ehab757-B27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cjca.2014.04.026","article-title":"Left ventricular remodelling in aortic stenosis","volume":"30","author":"Rassi","year":"2014","journal-title":"Can J Cardiol"},{"key":"2022102517141517900_ehab757-B28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacc.2009.12.074","article-title":"Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease","volume":"56","author":"Azevedo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B29","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jacc.2011.03.064","article-title":"Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis","volume":"58","author":"Dweck","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1503\/cjs.009517","article-title":"Regional differences in aortic valve replacements: atlantic Canadian experience","volume":"61","author":"McGuire","year":"2018","journal-title":"Can J Surg"},{"key":"2022102517141517900_ehab757-B31","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0002-9149(01)01501-6","article-title":"Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris","volume":"87","author":"Rapp","year":"2001","journal-title":"Am J Cardiol"},{"key":"2022102517141517900_ehab757-B32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (Astronomer) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B33","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J Med"},{"key":"2022102517141517900_ehab757-B34","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"key":"2022102517141517900_ehab757-B35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.amjcard.2008.04.060","article-title":"Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg)","volume":"102","author":"Dichtl","year":"2008","journal-title":"Am J Cardiol"},{"key":"2022102517141517900_ehab757-B36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000350896","article-title":"Angiotensin receptor blockers are associated with reduced fibrosis and interleukin-6 expression in calcific aortic valve disease","volume":"81","author":"C\u00f4t\u00e9","year":"2014","journal-title":"Pathobiology"},{"key":"2022102517141517900_ehab757-B37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.amjcard.2009.02.051","article-title":"Osteoporosis treatment and progression of aortic stenosis","volume":"104","author":"Skolnick","year":"2009","journal-title":"Am J Cardiol"},{"key":"2022102517141517900_ehab757-B38","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","article-title":"Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial","volume":"143","author":"Pawade","year":"2021","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B39","author":"A Randomized Trial of Angiotensin Receptor Blocker Fimasartan in Aortic Stenosis (ALFA Trial)","year":"2021"},{"key":"2022102517141517900_ehab757-B40","author":"The Aortic Valve DECalcification (AVADEC) Trial (AVADEC)"},{"key":"2022102517141517900_ehab757-B41","author":"Bicuspid Aortic Valve Stenosis and the Effect of Vitamin K2 on Calcium Metabolism on 18F-NaF PET\/MRI (BASIK-II)","year":"2021"},{"key":"2022102517141517900_ehab757-B42","author":"A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification (CAVS)","year":"2021"},{"key":"2022102517141517900_ehab757-B43","author":"Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)","year":"2021"},{"key":"2022102517141517900_ehab757-B44","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.119.044195","article-title":"Slowing progression of cardiovascular calcification with snf472 in patients on hemodialysis: results of a randomized phase 2b study","volume":"141","author":"Raggi","year":"2020","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B45","author":"Decalcification of the Aortic Valve by Vitamin K2 (Menaquinone-7) (DECAV-K2)","year":"2021"},{"key":"2022102517141517900_ehab757-B46","author":"Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD (DIP-CAVD)","year":"2021"},{"key":"2022102517141517900_ehab757-B47","author":"Early Aortic Valve Lipoprotein(a) Lowering Trial (EAVaLL)","year":"2021"},{"key":"2022102517141517900_ehab757-B48","author":"PCSK9 Inhibitors in the Progression of Aortic Stenosis","year":"2021"},{"key":"2022102517141517900_ehab757-B49","author":"Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis. (SALTIRE II)","year":"2021"},{"key":"2022102517141517900_ehab757-B50","author":"SLOW-Slower Progress of caLcificatiOn With Vitamin K2","year":"2021"},{"key":"2022102517141517900_ehab757-B51","author":"Vitamin K Supplement for Inhibition of the Progress in Aortic Valve Calcification (08-002)","year":"2021"},{"key":"2022102517141517900_ehab757-B52","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1161\/CIRCULATIONAHA.116.027011","article-title":"Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation","volume":"135","author":"Brandenburg","year":"2017","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B53","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/CIRCULATIONAHA.117.027776","article-title":"A rock and a hard place chiseling away at the multiple mechanisms of aortic stenosis","volume":"135","author":"Aikawa","year":"2017","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B54","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2353\/ajpath.2007.070251","article-title":"The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology","volume":"171","author":"Liu","year":"2007","journal-title":"Am J Pathol"},{"key":"2022102517141517900_ehab757-B55","first-page":"841","article-title":"Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves","volume":"13","author":"Rabkin-Aikawa","year":"2004","journal-title":"J Heart Valve Dis"},{"key":"2022102517141517900_ehab757-B56","first-page":"183","article-title":"Endothelial-to-mesenchymal transition in calcific aortic valve disease","volume":"36","author":"Ma","year":"2020","journal-title":"Acta Cardiol Sin"},{"key":"2022102517141517900_ehab757-B57","doi-asserted-by":"crossref","first-page":"e006339","DOI":"10.1161\/JAHA.117.006339","article-title":"Valve interstitial cells: the key to understanding the pathophysiology of heart valve calcification","volume":"6","author":"Rutkovskiy","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2022102517141517900_ehab757-B58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.carpath.2015.08.008","article-title":"Osseous and chondromatous metaplasia in calcific aortic valve stenosis","volume":"25","author":"Torre","year":"2016","journal-title":"Cardiovasc Pathol"},{"key":"2022102517141517900_ehab757-B59","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1161\/ATVBAHA.120.314789","article-title":"Cell-type transcriptome atlas of human aortic valves reveal cell heterogeneity and endothelial to mesenchymal transition involved in calcific aortic valve disease","volume":"40","author":"Xu","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yjmcc.2016.03.004","article-title":"Simulation of early calcific aortic valve disease in a 3D platform: a role for myofibroblast differentiation","volume":"94","author":"Hjortnaes","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"2022102517141517900_ehab757-B61","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.117.032291","article-title":"Spatiotemporal multi-omics mapping generates a molecular atlas of the aortic valve and reveals networks driving disease","volume":"138","author":"Schlotter","year":"2018","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yjmcc.2013.04.001","article-title":"Endothelial nitric oxide signaling regulates Notch1 in aortic valve disease","volume":"60","author":"Bosse","year":"2013","journal-title":"J Mol Cell Cardiol"},{"key":"2022102517141517900_ehab757-B63","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jacc.2018.12.042","article-title":"Relationship of Iron Deposition to Calcium Deposition in Human Aortic Valve Leaflets","volume":"73","author":"Morvan","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fcvm.2018.00197","article-title":"Comparing the role of mechanical forces in vascular and valvular calcification progression","volume":"5","author":"Gomel","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"2022102517141517900_ehab757-B65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.atherosclerosis.2014.11.026","article-title":"Early aortic valve inflammation precedes calcification: a longitudinal FDG-PET\/CT study","volume":"238","author":"Abdelbaky","year":"2015","journal-title":"Atherosclerosis"},{"key":"2022102517141517900_ehab757-B66","doi-asserted-by":"crossref","first-page":"100193","DOI":"10.1074\/jbc.RA120.015700","article-title":"ApoC-III is a novel inducer of calcification in human aortic valves","volume":"296","author":"Schlotter","year":"2021","journal-title":"J Biol Chem"},{"key":"2022102517141517900_ehab757-B67","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/heartjnl-2016-311040","article-title":"Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis","volume":"103","author":"Thomassen","year":"2017","journal-title":"Heart"},{"key":"2022102517141517900_ehab757-B68","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.atherosclerosis.2009.10.030","article-title":"Heart valve sclerosis predicts all-cause and cardiovascular mortality","volume":"209","author":"V\u00f6lzke","year":"2010","journal-title":"Atherosclerosis"},{"key":"2022102517141517900_ehab757-B69","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00380-020-01688-9","article-title":"Aortic valve calcification is subject to aortic stenosis severity and the underlying flow pattern","volume":"36","author":"Veulemans","year":"2021","journal-title":"Heart Vessels"},{"key":"2022102517141517900_ehab757-B70","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/ehjci\/jeaa096","article-title":"Sex differences in aortic valve calcification in severe aortic valve stenosis: association between computer tomography assessed calcification and valvular calcium concentrations","volume":"22","author":"Linde","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022102517141517900_ehab757-B71","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacbts.2021.02.005","article-title":"Artificial Intelligence Models Reveal Sex-Specific Gene Expression in Aortic Valve Calcification","volume":"6","author":"Sarajlic","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"2022102517141517900_ehab757-B72","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.bbadis.2019.04.014","article-title":"Lipopolysaccharide and interferon-\u03b3 team up to activate HIF-1\u03b1 via STAT1 in normoxia and exhibit sex differences in human aortic valve interstitial cells","volume":"1865","author":"Parra-Izquierdo","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2022102517141517900_ehab757-B73","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1161\/ATVBAHA.118.311504","article-title":"Calcification induced by type I interferon in human aortic valve interstitial cells is larger in males and blunted by a Janus Kinase inhibitor","volume":"38","author":"Parra-Izquierdo","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B74","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.3390\/ijms21165620","article-title":"Sex-specific features of calcific aortic valve disease","volume":"21","author":"Summerhill","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2022102517141517900_ehab757-B75","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0735-1097(02)02622-0","article-title":"Aortic valve sclerosis is associated with systemic endothelial dysfunction","volume":"41","author":"Poggianti","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B76","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.ajpath.2013.01.037","article-title":"Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling","volume":"182","author":"Richards","year":"2013","journal-title":"Am J Pathol"},{"key":"2022102517141517900_ehab757-B77","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10237-011-0306-2","article-title":"Experimental measurement of dynamic fluid shear stress on the ventricular surface of the aortic valve leaflet","volume":"11","author":"Yap","year":"2012","journal-title":"Biomech Model Mechanobiol"},{"key":"2022102517141517900_ehab757-B78","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/01.CIR.101.20.2345","article-title":"Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase","volume":"101","author":"Lee","year":"2000","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B79","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1152\/ajpheart.00392.2013","article-title":"Aortic valve sclerosis in mice deficient in endothelial nitric oxide synthase","volume":"306","author":"El Accaoui","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022102517141517900_ehab757-B80","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2008.11.029","article-title":"Inhibition of calcifying nodule formation in cultured porcine aortic valve cells by nitric oxide donors","volume":"602","author":"Kennedy","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"2022102517141517900_ehab757-B81","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1016\/j.biomaterials.2014.01.005","article-title":"The role of valvular endothelial cell paracrine signaling and matrix elasticity on valvular interstitial cell activation","volume":"35","author":"Gould","year":"2014","journal-title":"Biomaterials"},{"key":"2022102517141517900_ehab757-B82","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.niox.2019.04.007","article-title":"Nitric Oxide Site and mechanism of uncoupling of nitric-oxide synthase\u202f: Uncoupling by monomerization and other misconceptions","volume":"89","author":"Gebhart","year":"2019","journal-title":"Nitric Oxide"},{"key":"2022102517141517900_ehab757-B83","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab142","article-title":"Role of oxidative stress in calcific aortic valve disease and its therapeutic implications","author":"Greenberg","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2022102517141517900_ehab757-B84","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacc.2008.05.043","article-title":"Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans","volume":"52","author":"Miller","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B85","doi-asserted-by":"crossref","first-page":"e0123257","DOI":"10.1371\/journal.pone.0123257","article-title":"Endothelial-derived oxidative stress drives myofibroblastic activation and calcification of the aortic valve","volume":"10","author":"Farrar","year":"2015","journal-title":"PLoS One"},{"key":"2022102517141517900_ehab757-B86","doi-asserted-by":"crossref","first-page":"eabe3706","DOI":"10.1126\/sciadv.abe3706","article-title":"Nitric oxide prevents aortic valve calcification by S-nitrosylation of USP9X to activate NOTCH signaling","volume":"7","author":"Majumdar","year":"2021","journal-title":"Sci Adv"},{"key":"2022102517141517900_ehab757-B87","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature03940","article-title":"Mutations in NOTCH1 cause aortic valve disease","volume":"437","author":"Garg","year":"2005","journal-title":"Nature"},{"key":"2022102517141517900_ehab757-B88","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.yjmcc.2009.08.008","article-title":"Notch1 represses osteogenic pathways in aortic valve cells","volume":"47","author":"Nigam","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"2022102517141517900_ehab757-B89","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.116.024270","article-title":"Dipeptidyl peptidase-4 induces aortic valve calcifcation by inhibiting insulin-like growth factor-1 signaling in valvular interstitial cells","volume":"135","author":"Choi","year":"2017","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B90","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1093\/eurheartj\/ehab316","article-title":"DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells","volume":"42","author":"Wang","year":"2021","journal-title":"Eur Heart J"},{"key":"2022102517141517900_ehab757-B91","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.90.2.844","article-title":"Characterization of the early lesion of \u2018degenerative\u2019 valvular aortic stenosis: histological and immunohistochemical studies","volume":"90","author":"Otto","year":"1994","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B92","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/cvr\/20.10.760","article-title":"Endothelial cell orientation on aortic valve leaflets","volume":"20","author":"Deck","year":"1986","journal-title":"Cardiovasc Res"},{"key":"2022102517141517900_ehab757-B93","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10237-011-0301-7","article-title":"Experimental measurement of dynamic fluid shear stress on the aortic surface of the aortic valve leaflet","volume":"11","author":"Yap","year":"2012","journal-title":"Biomech Model Mechanobiol"},{"key":"2022102517141517900_ehab757-B94","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s10237-012-0375-x","article-title":"Computational assessment of bicuspid aortic valve wall-shear stress: implications for calcific aortic valve disease","volume":"11","author":"Chandra","year":"2012","journal-title":"Biomech Model Mechanobiol"},{"key":"2022102517141517900_ehab757-B95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cnm.2798","article-title":"Computational comparison of regional stress and deformation characteristics in tricuspid and bicuspid aortic valve leaflets","volume":"33","author":"Cao","year":"2017","journal-title":"Int J Numer Method Biomed Eng"},{"key":"2022102517141517900_ehab757-B96","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1161\/CIRCULATIONAHA.113.007851","article-title":"Bicuspid aortic valve identifying knowledge gaps and rising to the challenge from the international bicuspid aortic valve consortium (BAVCON)","volume":"129","author":"Michelena","year":"2014","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B97","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.0000155623.48408.C5","article-title":"Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation","volume":"111","author":"Roberts","year":"2005","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B98","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4065\/74.1.14","article-title":"Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 additional cases","volume":"74","author":"Sabet","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"2022102517141517900_ehab757-B99","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/ATVBAHA.118.312233","article-title":"Disturbed flow increases UBE2C (Ubiquitin E2 Ligase C) via Loss of miR-483-3p, inducing aortic valve calcification by the pVHL (von Hippel-Lindau Protein) and HIF-1\u03b1 (Hypoxia-Inducible Factor-1\u03b1) pathway in endothelial cells","volume":"39","author":"Fernandez Esmerats","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41569-019-0239-5","article-title":"Endothelial responses to shear stress in atherosclerosis: a novel role for developmental genes","volume":"17","author":"Souilhol","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2022102517141517900_ehab757-B101","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/HYPERTENSIONAHA.109.131508","article-title":"Retrograde flow and shear rate acutely impair endothelial function in humans","volume":"53","author":"Thijssen","year":"2009","journal-title":"Hypertension"},{"key":"2022102517141517900_ehab757-B102","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1002\/bit.25291","article-title":"Effects of shear stress pattern and magnitude on mesenchymal transformation and invasion of aortic valve endothelial cells","volume":"111","author":"Mahler","year":"2014","journal-title":"Biotechnol Bioeng"},{"key":"2022102517141517900_ehab757-B103","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/ATVBAHA.119.313248","article-title":"NF\u03baB (nuclear factor \u03ba-light-chain enhancer of activated B cells) activity regulates cell-type-specific and context-specific susceptibility to calcification in the aortic valve","volume":"40","author":"Gee","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B104","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/ATVBAHA.112.300504","article-title":"Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells","volume":"33","author":"Mahler","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B105","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0002-9440(10)62520-5","article-title":"Aortic valve endothelial cells undergo transforming growth factor-\u03b2-mediated and non-transforming growth factor-\u03b2-mediated transdifferentiation in Vitro","volume":"159","author":"Paranya","year":"2001","journal-title":"Am J Pathol"},{"key":"2022102517141517900_ehab757-B106","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jacc.2019.04.045","article-title":"Microfissure on the aortic valve endothelium: the root of all evil?","volume":"74","author":"Ma","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B107","first-page":"281","article-title":"Surface structure of the human cardiac valve. A comparative study of normal and diseased valves","volume":"19","author":"Harasaki","year":"1978","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"2022102517141517900_ehab757-B108","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/eurheartj\/ehaa770","article-title":"Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease","volume":"42","author":"Akhmedov","year":"2021","journal-title":"Eur Heart J"},{"key":"2022102517141517900_ehab757-B109","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2014.05.933","article-title":"Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis","volume":"235","author":"Syv\u00e4ranta","year":"2014","journal-title":"Atherosclerosis"},{"key":"2022102517141517900_ehab757-B110","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","article-title":"Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis","volume":"73","author":"Zheng","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B111","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"key":"2022102517141517900_ehab757-B112","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jamacardio.2019.1581","article-title":"Genetic variation in LPA, calcific aortic valve stenosis in patients undergoing cardiac surgery, and familial risk of aortic valve microcalcification","volume":"4","author":"Perrot","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2022102517141517900_ehab757-B113","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/CIRCULATIONAHA.120.045826","article-title":"Lipoprotein(a) in Alzheimer, atherosclerotic, cerebrovascular, thrombotic, and valvular disease","volume":"141","author":"Larsson","year":"2020","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B114","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/339303a0","article-title":"Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis","volume":"339","author":"Hajjar","year":"1989","journal-title":"Nature"},{"key":"2022102517141517900_ehab757-B115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/01.ATV.10.2.240","article-title":"Lipoprotein(a), fibrin binding, and plasminogen activation","volume":"10","author":"Loscalzo","year":"1990","journal-title":"Arteriosclerosis"},{"key":"2022102517141517900_ehab757-B116","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI119671","article-title":"Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus","volume":"100","author":"Hughes","year":"1997","journal-title":"J Clin Invest"},{"key":"2022102517141517900_ehab757-B117","doi-asserted-by":"crossref","first-page":"12591","DOI":"10.1073\/pnas.95.21.12591","article-title":"Fibrinogen deficiency reduces vascular accumulation of apolipoprotein(a) and development of atherosclerosis in apolipoprotein(a) transgenic mice","volume":"95","author":"Lou","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022102517141517900_ehab757-B118","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.115.016757","article-title":"Autotaxin derived from lipoprotein(a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve","volume":"132","author":"Bouchareb","year":"2015","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B119","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jacbts.2020.04.016","article-title":"An (Auto)Taxing effort to mechanistically link obesity and calcific aortic valve disease","volume":"5","author":"Rogers","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"2022102517141517900_ehab757-B120","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/heartjnl-2019-315840","article-title":"ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis","volume":"106","author":"Capoulade","year":"2020","journal-title":"Heart"},{"key":"2022102517141517900_ehab757-B121","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.jacc.2004.07.054","article-title":"Induction of local angiotensin II-producing systems in stenotic aortic valves","volume":"44","author":"Helske","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B122","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jacc.2013.05.105","article-title":"Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization","volume":"63","author":"Mahmut","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B123","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ehjci\/jew013","article-title":"Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study","volume":"18","author":"Tastet","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022102517141517900_ehab757-B124","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jamacardio.2019.2202","article-title":"Systolic Blood Pressure and Risk of Valvular Heart Disease: a Mendelian Randomization Study","volume":"4","author":"Nazarzadeh","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2022102517141517900_ehab757-B125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/ATVBAHA.113.302610","article-title":"A novel mouse model of aortic valve stenosis induced by direct wire injury","volume":"34","author":"Honda","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B126","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCULATIONAHA.119.041868","article-title":"Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease through the Resolvin E1 and ChemR23 Axis","volume":"142","author":"Artiach","year":"2020","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B127","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.051052","article-title":"Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis","volume":"125","author":"Dweck","year":"2012","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cjco.2019.03.004","article-title":"Lipoprotein(a), oxidized phospholipids, and aortic valve microcalcification assessed by 18F-sodium fluoride positron emission tomography and computed tomography","volume":"1","author":"Despr\u00e9s","year":"2019","journal-title":"CJC Open"},{"key":"2022102517141517900_ehab757-B129","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab273","article-title":"Innate and adaptative immunity: the understudied driving force of heart valve disease","author":"Bartoli-Leonard","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2022102517141517900_ehab757-B130","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jtcvs.2017.01.052","article-title":"The shift of macrophages toward M1 phenotype promotes aortic valvular calcification","volume":"153","author":"Li","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2022102517141517900_ehab757-B131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.atherosclerosis.2020.02.016","article-title":"Innate and adaptive immunity in cardiovascular calcification","volume":"306","author":"Passos","year":"2020","journal-title":"Atherosclerosis"},{"key":"2022102517141517900_ehab757-B132","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.yjmcc.2014.02.014","article-title":"P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease","volume":"72","author":"El Husseini","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2022102517141517900_ehab757-B133","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/CIRCGEN.119.002617","article-title":"Genetic association analyses highlight IL6, ALPL, and NAV1 As 3 new susceptibility genes underlying calcific aortic valve stenosis","volume":"12","author":"Th\u00e9riault","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2022102517141517900_ehab757-B134","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/ATVBAHA.112.249854","article-title":"Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation","volume":"32","author":"Gon\u00e7alves","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41569-018-0153-2","article-title":"Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease","volume":"16","author":"Boffa","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2022102517141517900_ehab757-B136","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/cvr\/cvy111","article-title":"DNA methylation of a PLPP3 MIR transposon-based enhancer promotes an osteogenic programme in calcific aortic valve disease","volume":"114","author":"Mkannez","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2022102517141517900_ehab757-B137","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/01.RES.0000171451.88616.c2","article-title":"Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification?","volume":"96","author":"Nadra","year":"2005","journal-title":"Circ Res"},{"key":"2022102517141517900_ehab757-B138","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmat4519","article-title":"Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques","volume":"15","author":"Hutcheson","year":"2016","journal-title":"Nat Mater"},{"key":"2022102517141517900_ehab757-B139","doi-asserted-by":"crossref","first-page":"eabb1244","DOI":"10.1126\/sciadv.abb1244","article-title":"Annexin A1-dependent tethering promotes extracellular vesicle aggregation revealed with single-extracellular vesicle analysis","volume":"6","author":"Rogers","year":"2020","journal-title":"Sci Adv"},{"key":"2022102517141517900_ehab757-B140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1054-8807(00)00043-0","article-title":"Matrix metalloproteinase expression in nonrheumatic aortic stenosis","volume":"9","author":"Edep","year":"2000","journal-title":"Cardiovasc Pathol"},{"key":"2022102517141517900_ehab757-B141","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/CIRCRESAHA.110.234146","article-title":"Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification","volume":"108","author":"New","year":"2011","journal-title":"Circ Res"},{"key":"2022102517141517900_ehab757-B142","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/ATVBAHA.120.314143","article-title":"A role for MMP-10 (matrix metalloproteinase-10) in calcific aortic valve stenosis","volume":"40","author":"Matilla","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B143","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/ATVBAHA.108.182394","article-title":"Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix","volume":"29","author":"Yip","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B144","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/ATVBAHA.109.198267","article-title":"Vascular endothelial growth factor-secreting mast cells and myofibroblasts: a novel self-perpetuating angiogenic pathway in aortic valve stenosis","volume":"30","author":"Syv\u00e4Ranta","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B145","first-page":"415","article-title":"Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve Disease","author":"Gendron","year":"2021"},{"key":"2022102517141517900_ehab757-B146","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1476","article-title":"Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis","volume":"12","author":"Yoshioka","year":"2006","journal-title":"Nat Med"},{"key":"2022102517141517900_ehab757-B147","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0008-6363(96)88547-6","article-title":"Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart","volume":"29","author":"Katwa","year":"1995","journal-title":"Cardiovasc Res"},{"key":"2022102517141517900_ehab757-B148","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1161\/01.CIR.0000035655.45453.D2","article-title":"Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma","volume":"106","author":"O'Brien","year":"2002","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B149","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehi706","article-title":"Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves","volume":"27","author":"Helske","year":"2006","journal-title":"Eur Heart J"},{"key":"2022102517141517900_ehab757-B150","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.atherosclerosis.2012.10.055","article-title":"Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice","volume":"226","author":"Fujisaka","year":"2013","journal-title":"Atherosclerosis"},{"key":"2022102517141517900_ehab757-B151","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jacc.2006.11.043","article-title":"Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits","volume":"49","author":"Arishiro","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B152","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijcard.2009.05.054","article-title":"Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis","volume":"145","author":"C\u00f4t\u00e9","year":"2010","journal-title":"Int J Cardiol"},{"key":"2022102517141517900_ehab757-B153","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcmg.2019.09.005","article-title":"Plasma ACE2 activity predicts mortality in aortic stenosis and is associated with severe myocardial fibrosis","volume":"13","author":"Ramchand","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022102517141517900_ehab757-B154","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1365-2362.2011.02522.x","article-title":"Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves","volume":"41","author":"C\u00f4t\u00e9","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"2022102517141517900_ehab757-B155","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/eci.12169","article-title":"Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis","volume":"43","author":"Capoulade","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"2022102517141517900_ehab757-B156","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000140723.15274.53","article-title":"Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis","volume":"110","author":"Rosenhek","year":"2004","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B157","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archinte.165.8.858","article-title":"Angiotensin-converting enzyme inhibitors and change in aortic valve calcium","volume":"165","author":"O'Brien","year":"2005","journal-title":"Arch Intern Med"},{"key":"2022102517141517900_ehab757-B158","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/ehjci\/jev043","article-title":"A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril in Aortic Stenosis (RIAS trial)","volume":"16","author":"Bull","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022102517141517900_ehab757-B159","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1093\/ndt\/gft310","article-title":"Aortic valve calcification in chronic kidney disease","volume":"28","author":"Rattazzi","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"2022102517141517900_ehab757-B160","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/cvr\/cvab038","article-title":"From organic and inorganic phosphates to valvular and vascular calcifications","volume":"117","author":"B\u00e4ck","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2022102517141517900_ehab757-B161","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijcard.2014.10.065","article-title":"Inverse association between bone mineral density and risk of aortic stenosis in men and women in EPIC-Norfolk prospective study","volume":"178","author":"Pfister","year":"2015","journal-title":"Int J Cardiol"},{"key":"2022102517141517900_ehab757-B162","doi-asserted-by":"crossref","first-page":"e006044","DOI":"10.1161\/JAHA.117.006044","article-title":"Prevalence and outcomes of left-sided valvular heart disease associated with chronic kidney disease","volume":"6","author":"Samad","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2022102517141517900_ehab757-B163","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jacc.2018.10.068","article-title":"Kidney dysfunction and the risk of developing aortic stenosis","volume":"73","author":"Vavilis","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B164","doi-asserted-by":"crossref","first-page":"e1088","DOI":"10.1161\/CIR.0000000000000979","article-title":"Evaluation and management of aortic stenosis in chronic kidney disease: a scientific statement from the American Heart Association","volume":"143","author":"Shroff","year":"2021","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B165","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3389\/fcell.2020.00862","article-title":"The role of Wnt\/\u03b2-catenin pathway mediators in aortic valve stenosis","volume":"8","author":"Khan","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2022102517141517900_ehab757-B166","doi-asserted-by":"crossref","first-page":"31496","DOI":"10.1074\/jbc.272.50.31496","article-title":"Cloning and targeted deletion of the mouse fetuin gene","volume":"272","author":"Jahnen-Dechent","year":"1997","journal-title":"J Biol Chem"},{"key":"2022102517141517900_ehab757-B167","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI17202","article-title":"The serum protein alpha 2-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopic calcification","volume":"112","author":"Schafer","year":"2003","journal-title":"J Clin Invest"},{"key":"2022102517141517900_ehab757-B168","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1681\/ASN.2008060572","article-title":"Jahnen-Dechent W. Fetuin-A protects against atherosclerotic calcification in CKD","volume":"20","author":"Westenfeld","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2022102517141517900_ehab757-B169","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2018.04.115","article-title":"Fetuin A in aortic stenosis and valve calcification: not crystal clear","volume":"265","author":"Carracedo","year":"2018","journal-title":"Int J Cardiol"},{"key":"2022102517141517900_ehab757-B170","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijcard.2018.03.070","article-title":"Impact of Fetuin-A on progression of calcific aortic valve stenosis - The COFRASA - GENERAC study","volume":"265","author":"Kubota","year":"2018","journal-title":"Int J Cardiol"},{"key":"2022102517141517900_ehab757-B171","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/eurheartj\/ehp158","article-title":"Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients","volume":"30","author":"Koos","year":"2009","journal-title":"Eur Heart J"},{"key":"2022102517141517900_ehab757-B172","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/acel.12494","article-title":"Deficiency in the anti-aging gene Klotho promotes aortic valve fibrosis through AMPK\u03b1-mediated activation of RUNX2","volume":"15","author":"Chen","year":"2016","journal-title":"Aging Cell"},{"key":"2022102517141517900_ehab757-B173","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.7569894","article-title":"Vitamin K and energy transduction: a base strength amplification mechanism","volume":"269","author":"Dowd","year":"1995","journal-title":"Science"},{"key":"2022102517141517900_ehab757-B174","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1038\/s41598-020-63013-8","article-title":"Matrix Gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease","volume":"10","author":"Jaminon","year":"2020","journal-title":"Sci Rep"},{"key":"2022102517141517900_ehab757-B175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jphs.2018.03.004","article-title":"Matrix Gla protein negatively regulates calcification of human aortic valve interstitial cells isolated from calcified aortic valves","volume":"136","author":"Chiyoya","year":"2018","journal-title":"J Pharmacol Sci"},{"key":"2022102517141517900_ehab757-B176","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1538-7836.2003.00023.x","article-title":"Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats","volume":"1","author":"Sweatt","year":"2003","journal-title":"J Thromb Haemost"},{"key":"2022102517141517900_ehab757-B177","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein","volume":"386","author":"Luo","year":"1997","journal-title":"Nature"},{"key":"2022102517141517900_ehab757-B178","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/ATVBAHA.114.304823","article-title":"Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system","volume":"35","author":"Viegas","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B179","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41581-018-0072-9","article-title":"Lipid management in patients with chronic kidney disease","volume":"14","author":"Ferro","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2022102517141517900_ehab757-B180","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/01.HYP.0000178102.85718.66","article-title":"Correlates of systolic hypertension in patients with chronic kidney disease","volume":"46","author":"Agarwal","year":"2005","journal-title":"Hypertension"},{"key":"2022102517141517900_ehab757-B181","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/jamacardio.2019.3903","article-title":"Association of low-density lipoprotein cholesterol with risk of aortic valve stenosis in familial hypercholesterolemia","volume":"4","author":"Mundal","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2022102517141517900_ehab757-B182","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease","volume":"29","author":"Stewart","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B183","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCGEN.119.002711","article-title":"Genetic determinants of lipids and cardiovascular disease outcomes: a wide-angled Mendelian randomization investigation","volume":"12","author":"Allara","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"2022102517141517900_ehab757-B184","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2022102517141517900_ehab757-B185","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jacc.2009.10.053","article-title":"Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients","volume":"55","author":"Koh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jendso\/bvaa057","article-title":"Statin use is associated with insulin resistance in participants of the canadian multicentre osteoporosis study","volume":"4","author":"Rees-Milton","year":"2020","journal-title":"J Endocr Soc"},{"key":"2022102517141517900_ehab757-B187","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/eurheartj\/ehz310","article-title":"Statin therapy increases lipoprotein(a) levels","volume":"41","author":"Tsimikas","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102517141517900_ehab757-B188","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/nsr\/nwu028","article-title":"Novel applications of statins for bone regeneration","volume":"2","author":"Shah","year":"2015","journal-title":"Natl Sci Rev"},{"key":"2022102517141517900_ehab757-B189","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/17512433.2015.1011125","article-title":"Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms","volume":"8","author":"Okuyama","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2022102517141517900_ehab757-B190","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0735-1097(02)02496-8","article-title":"Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community","volume":"40","author":"Bellamy","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B191","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1001\/jamacardio.2018.3798","article-title":"Association of mild to moderate aortic valve stenosis progression with higher lipoprotein(a) and oxidized phospholipid levels: secondary analysis of a randomized clinical trial","volume":"3","author":"Capoulade","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2022102517141517900_ehab757-B192","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis a prospective mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"2022102517141517900_ehab757-B193","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jamacardio.2020.0246","article-title":"Association of FADS1\/2 locus variants and polyunsaturated fatty acids with aortic stenosis","volume":"5","author":"Chen","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022102517141517900_ehab757-B194","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/joim.12519","article-title":"Autotaxin interacts with lipoprotein(a) and oxidized phospholipids in predicting the risk of calcific aortic valve stenosis in patients with coronary artery disease","volume":"280","author":"Nsaibia","year":"2016","journal-title":"J Intern Med"},{"key":"2022102517141517900_ehab757-B195","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamacardio.2020.0728","article-title":"An exploratory analysis of proprotein convertase subtilisin\/kexin type 9 inhibition and aortic stenosis in the FOURIER trial","volume":"5","author":"Bergmark","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022102517141517900_ehab757-B196","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jacbts.2020.05.004","article-title":"Genetic and in vitro inhibition of PCSK9 and calcific aortic valve stenosis","volume":"5","author":"Perrot","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"2022102517141517900_ehab757-B197","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.jacc.2018.09.063","article-title":"PCSK9 involvement in Aortic Valve Calcification","volume":"72","author":"Poggio","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B198","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/CIRCULATIONAHA.113.001969","article-title":"AMG145, a monoclonal antibody against proprotein convertase subtilisin kexin type 9, significantly reduces lipoprotein(a) in hypercholesterolemic patients receiving statin therapy: an analysis from the LDL-C assessment with proprotein convertase subtilisi","volume":"128","author":"Desai","year":"2013","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B199","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2014.01.006","article-title":"Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials","volume":"63","author":"Raal","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjcard.2016.09.010","article-title":"Effect of alirocumab on lipoprotein(a) Over \u22651.5 Years (from the Phase 3 ODYSSEY Program)","volume":"119","author":"Gaudet","year":"2017","journal-title":"Am J Cardiol"},{"key":"2022102517141517900_ehab757-B201","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk insights from the FOURIER trial","volume":"139","author":"O\u2019Donoghue","year":"2019","journal-title":"Circulation"},{"key":"2022102517141517900_ehab757-B202","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jamacardio.2018.1470","article-title":"Association of LPA variants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies: A Mendelian randomization analysis","volume":"3","author":"Burgess","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2022102517141517900_ehab757-B203","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamacardio.2019.1041","article-title":"Estimation of the required lipoprotein(a)-lowering therapeutic effect size for reduction in coronary heart disease outcomes: a Mendelian randomization analysis","volume":"4","author":"Lamina","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2022102517141517900_ehab757-B204","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med"},{"key":"2022102517141517900_ehab757-B205","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaa063","article-title":"Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction, and estimating benefits from novel interventions","author":"Welsh","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2022102517141517900_ehab757-B206","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2017.10.027","article-title":"Effects of vitamin K antagonist on aortic valve degeneration in non-valvular atrial fibrillation patients: prospective 4-year observational study","volume":"160","author":"Yamamoto","year":"2017","journal-title":"Thromb Res"},{"key":"2022102517141517900_ehab757-B207","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/15701611113119990146","article-title":"Vertebral Fractures And Vascular Calcifications Study Group. Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients","volume":"13","author":"Fusaro","year":"2015","journal-title":"Curr Vasc Pharmacol"},{"key":"2022102517141517900_ehab757-B208","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjcard.2005.05.014","article-title":"Relation of oral anticoagulation to cardiac valvular and coronary calcium assessed by multislice spiral computed tomography","volume":"96","author":"Koos","year":"2005","journal-title":"Am J Cardiol"},{"key":"2022102517141517900_ehab757-B209","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/ehjci\/jeaa065","article-title":"Association of aortic valve calcification and vitamin K antagonist treatment","volume":"21","author":"S\u00f8nderskov","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022102517141517900_ehab757-B210","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1681\/ASN.2016060651","article-title":"Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis","volume":"28","author":"Nigwekar","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2022102517141517900_ehab757-B211","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCRESAHA.117.311194","article-title":"Deficiency of natriuretic peptide receptor 2 promotes bicuspid aortic valves, aortic valve disease, left ventricular dysfunction, and ascending aortic dilatations in mice","volume":"122","author":"Blaser","year":"2018","journal-title":"Circ Res"},{"key":"2022102517141517900_ehab757-B212","doi-asserted-by":"crossref","first-page":"H1763","DOI":"10.1152\/ajpheart.51.2008","article-title":"Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress","volume":"295","author":"Zhou","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2022102517141517900_ehab757-B213","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00395-014-0421-1","article-title":"Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition","volume":"109","author":"Fraccarollo","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"2022102517141517900_ehab757-B214","first-page":"A123","article-title":"Abstract 123: Activation of Oxidized Soluble Guanylate Cyclase Slows Progression of Aortic Valve Calcification","volume":"39","author":"Zhang","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022102517141517900_ehab757-B215","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1111\/bcp.13752","article-title":"First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification","volume":"84","author":"Perell\u00f3","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"2022102517141517900_ehab757-B216","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.ajpath.2017.02.012","article-title":"Interferon-\u03b3 Released by Activated CD8+ T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves","volume":"187","author":"Nagy","year":"2017","journal-title":"Am J Pathol"},{"key":"2022102517141517900_ehab757-B217","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yjmcc.2003.09.015","article-title":"Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification","volume":"36","author":"Kaden","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"2022102517141517900_ehab757-B218","doi-asserted-by":"crossref","first-page":"e65201","DOI":"10.1371\/journal.pone.0065201","article-title":"Osteoprotegerin inhibits aortic valve calcification and preserves valve function in hypercholesterolemic mice","volume":"8","author":"Weiss","year":"2013","journal-title":"PLoS One"},{"key":"2022102517141517900_ehab757-B219","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jacc.2010.05.050","article-title":"Bisphosphonate use and prevalence of valvular and vascular calcification in women MESA (The Multi-Ethnic Study of Atherosclerosis)","volume":"56","author":"Elmariah","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2022102517141517900_ehab757-B220","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/heartjnl-2021-319376","article-title":"Threshold effect for lipoprotein(a) in aortic stenosis","volume":"107","author":"Tzolos","year":"2021","journal-title":"Heart"},{"key":"2022102517141517900_ehab757-B221","first-page":"364310","article-title":"Animal models of calcific aortic valve disease","volume":"2011","author":"Sider","year":"2011","journal-title":"Int J Inflam"},{"key":"2022102517141517900_ehab757-B222","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCRESAHA.120.317979","article-title":"Multi-omics approaches to define calcific aortic valve disease pathogenesis","volume":"128","author":"Blaser","year":"2021","journal-title":"Circ Res"},{"key":"2022102517141517900_ehab757-B223","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/nano8050296","article-title":"Engineering a 3D-bioprinted model of human heart valve disease using nanoindentation-based biomechanics","volume":"8","author":"D van der","year":"2018","journal-title":"Nanomaterials"},{"key":"2022102517141517900_ehab757-B224","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41569-018-0123-8","article-title":"Cardiovascular calcification: artificial intelligence and big data accelerate mechanistic discovery","volume":"16","author":"Rogers","year":"2019","journal-title":"Nat Rev Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/7\/683\/46629896\/ehab757.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/7\/683\/46629896\/ehab757.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T14:22:52Z","timestamp":1666707772000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/7\/683\/6440005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":224,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,11,25]]},"published-print":{"date-parts":[[2022,2,12]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab757","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,14]]},"published":{"date-parts":[[2021,11,25]]}}}